Commentary: Physician-scientist's frustrations fester

Neuropsychopharmacology

Volumn 34, Issue 1, 2009, Pages 1-5

  Bloom, Floyd E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUSTRATION; HEALTH CARE SYSTEM; MEDICAL RESEARCH; NOTE; PHYSICIAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; SCIENTIST; UNITED STATES;

BIOMEDICAL RESEARCH; DELIVERY OF HEALTH CARE; DRUG DISCOVERY; DRUG INDUSTRY; NEUROPHARMACOLOGY; PSYCHOPHARMACOLOGY; RESEARCH SUPPORT AS TOPIC; UNITED STATES;

EID: 57649118530     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2008.181     Document Type: Note

References (20)

1. Abelson R, Freudenheim M (2008). Even the insured feel strain of health costs. In: New York Times. 4 May 2008.
2. Adams K, Corrigan JM (eds) (2003). Priority Areas for National Action: Transforming Health Care Quality. National Academy Press: Washington, DC.
3. Aiken LH, Clarke SP, Sloane DM, Sochalski J, Silber JH (2002). Hospital nurse staffing and patient mortality, nurse burnout, and job dissatisfaction. JAMA 288: 1987-1993.
4. Anton RF (2008). Genetic basis for predicting response to naltrexone in the treatment of alcohol dependence. Pharmacogenomics 9: 655-658.
5. Blendon RJ, Altman DE, Deane C, Benson JM, Brodie M, Buhr T (2008). Health care in the 2008 presidential primaries. N Engl J Med 358: 414-422.
6. Bloom FE (2003). Presidential address. Science as a way of life: perplexities of a physician-scientist. Science 300: 1680-1685.
7. Committee on Quality of Health Care in America, IoM (2001). Crossing the Quality Chasm: A New Health System for the 21st Century. National Academy Press: Washington, DC.
8. Education, ACGME. (2002). Report of theWorking Group on Resident Duty Hours and the Learning Environment. http://www.acgme.org/acWebsite/ dutyhours/dh_wdex. asp, accessed 9/25/08.
9. Garbutt JC (2006). Medications for the treatment of alcohol dependence. Am Fam Physician 74: 1836.
10. Garbutt JC, Kranzler HR, O'Malley SS, Gastfriend DR, Pettinati HM, Silverman BL et al. (2005). Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA 293: 1617-1625.
11. http://clinicaltrials.gov/ct2/show/NCT00606476?term=bapineuzumab& rank=6,(2008).
12. http://www.brokenpipeline.org/,(2008). Compendium of 7 academic centers efforts to restore NIH funding increments.
13. Kohn LT, Corrigan JM, Donaldson MS. (eds). (2000). To Err is Human: Building a Safer Health System. National Academy Press: Washington, DC.
14. Ludmerer KM (1999). Time to Heal, Vol., Oxford University Press: New York.
15. Murillo H, Reece EA, Snyderman R, Sung NS (2006). Meeting the challenges facing clinical research: solutions proposed by leaders of medical specialty and clinical research societies. Acad Med 81: 107-112.
16. Nathan D (2002). Careers in translational clinical researchFhistorical perspectives, future challenges. JAMA 287: 2424-2427.
17. O'Kane M, Corrigan J, Foote SM, Tunis SR, Isham GJ, Nichols LM et al. (2008). Crossroads in quality. Health Aff (Millwood) 27: 749-758.
18. Sonnert G, Holton G (2002). Ivory Bridges, Vol., MIT Press: Cambridge, MA.
19. Sung NS, Crowley Jr WF, Genel M, Salber P, Sandy L, Sherwood LM et al. (2003). Central challenges facing the national clinical research enterprise. JAMA 289: 1278-1287.
20. Williams M (2003). Genome-based drug discovery: prioritizing disease-susceptibility/ disease-associated genes as novel drug targets for schizophrenia. Curr Opin Investig Drugs 4: 31-36.